#plaque

A recent study randomized those with a moderate long-term risk of heart attack to receive Crestor (rosuvastatin) or a placebo.

This increased risk is not driven by differences in plaque buildup in the arteries compared with those who are HIV negative.

A recent study found that factors other than coronary plaque likely drive this sex-based difference.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Additionally, researchers found that those with an unsupressed viral load had higher risk than those people with undetectable HIV.

Hepatitis C is linked with plaque buildup in the arteries, a precursor to cardiovascular disease.

The protease inhibitor Reyataz (atazanavir) negatively affects the normal functioning of blood vessels, as has been seen with other protease i...

A method for diagnosing clogged arteries in HIV-negative patients works well in HIV-positive patients too, according to the authors of a resea...